Siemens Healthineers is in early discussions with multiple major PE firms, including Blackstone, CVC Capital Partners, and KKR, over a possible sale of its Laboratory Diagnostics division.
Archives
What Eko Health’s AI stethoscope can teach us about AI adoption in healthcare
An AI-powered digital stethoscope developed by a California-based medtech company called Eko Health has been found to detect heart conditions with significantly greater sensitivity than doctors using analogue stethoscopes in a trial with 200 UK GP practices. But the same study also found that 70% of these GP surgeries had stopped using them or were only using them infrequently a year after they were given them. In a conversation with HBI, Alfred Olivares and Nick Kovacev, who work for US technology consultancy HTEC, suggested some of the reasons for this, and the broader lessons for health tech companies trying to develop impactful AI tools.
September 19, 2025
Dutch youth mental health provider Yes We Can bought by PE with plans to expand to UK and Switzerland
Dutch PE firm Bencis Capital Partners is buying Yes We Can, a Dutch mental healthcare provider focused on providing care to young people. The group has plans to expand its relatively unique model of care to the UK and Switzerland.
September 18, 2025
Hungary bans private imaging groups from participating in public system
The government of Hungary is banning private providers of diagnostic imaging from providing publicly funded services. Pan-European diagnostics and outpatient group Affidea, the biggest private imaging provider in the country, tells us they will continue to operate in the country for privately funded patients.
September 16, 2025
Advent sells Czech generics maker Zentiva to GTCR for €4.1bn
US PE firm Advent International has sold Zentiva, a Czech pharma business focused on generics, to GTCR, another US PE firm, for €4.1 billion.
September 12, 2025
TVM raises $150m and Somerset Indus raises $250m to expand access to private healthcare in Asia
Two Asia-based PE firms have separately raised significant amounts to invest in healthcare services in the continent.
September 11, 2025
Ribera Salud enters Poland
Spanish hospital group Ribera Salud has entered the Polish market. It has bought a small imaging and outpatient chain in Warsaw called Multi Med.
September 11, 2025
CapVest acquires German generics maker Stada for €10bn
London-based PE firm CapVest has bought a 70% stake in German pharma company Stada, in Europe’s biggest healthcare deal of 2025 so far. Bain Capital and Cinven, the company’s joint PE owners since 2017, will continue to hold the remaining 30%.
September 11, 2025
HBI Deals+Insights briefing September 2025: Intelligence members
Click here to download your August/September 2025 Deals+Insights double edition. In September’s double edition we cover two major M&A deals in Europe’s dental sector: the acquisition of the UK’s largest dental group, mydentist, by Bridgepoint, and the acquisition of Spain’s largest dental group, Donte, by Canadian pension fund Ontario Teachers’ Pension Plan. Other deals covered […]
September 10, 2025
HBI Deals+Insights briefing September 2025: Deals+Insights members
Click here to download your August/September 2025 Deals+Insights double edition. In September’s double edition we cover two major M&A deals in Europe’s dental sector: the acquisition of the UK’s largest dental group, mydentist, by Bridgepoint, and the acquisition of Spain’s largest dental group, Donte, by Canadian pension fund Ontario Teachers’ Pension Plan. Other deals covered […]
September 10, 2025
Macquarie buys 40% stake in Luz Saude
Infrastructure investor Macquarie has bought a 40% stake in Luz Saude, Portugal’s second largest private hospital group by revenue, for a base consideration of €310 million. The deal values Luz Saude at €1.1 billion in terms of enterprise value, a 9.5x multiple of the group’s 2024 EBITDA.
September 9, 2025
Organ transplant tech startup OrganOx bought by med tech company for $1.5bn
OrganOx, an Oxford University spinout that has developed a new technology for preserving organs, has been bought by Japan-based med tech firm Terumo Corporation for $1.5 billion. This makes it the largest ever Oxford University spinout deal.
